Abu Dhabi [UAE], May 15 (ANI/WAM): Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health - Abu Dhabi (DoH) has stated that the launch of Neuralink's UAE-PRIME clinical trial in Abu Dhabi - the first international site outside North America - marks a powerful moment for the future of health.

He made the statements following the recent announcement by Neuralink regarding the launch of their first clinical trial in the Middle East, UAE-PRIME, at Cleveland Clinic Abu Dhabi in partnership with DoH, adding: "In collaboration with Cleveland Clinic Abu Dhabi, we are proud to enable the safe and responsible advancement of brain-computer interface technology, offering renewed hope to individuals living with severe neurological conditions."

Also Read | India-Pakistan Tension: Indian Army Killed 2 Turkish Military Operatives During Operation Sindoor, Says Sources.

He noted that this partnership exemplifies "Abu Dhabi's commitment to innovation in health and life sciences - driving the acceleration of breakthrough technologies that are purposefully tested, ethically governed, and made accessible to patients around the world." (ANI/WAM)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)